Clinical trials
Completed Phase 2 Hepatitis C, Chronic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
161 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 3 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 5 |
| 2005 | 13 |
| 2006 | 7 |
| 2007 | 15 |
| 2008 | 11 |
| 2009 | 11 |
| 2010 | 8 |
| 2011 | 20 |
| 2012 | 16 |
| 2013 | 15 |
| 2014 | 7 |
| 2015 | 11 |
| 2016 | 6 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 161 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 15 |
| Hoffmann-La Roche | 14 |
| Merck Sharp & Dohme LLC | 14 |
| AbbVie | 7 |
| Vertex Pharmaceuticals Incorporated | 6 |
| Boehringer Ingelheim | 5 |
| Bristol-Myers Squibb | 5 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 5 |
| Romark Laboratories L.C. | 5 |
| AbbVie (prior sponsor, Abbott) | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C, Chronic | 161 |
| Hepatitis C | 58 |
| Hepatitis | 6 |
| Liver Diseases | 6 |
| Fibrosis | 5 |
| HIV Infections | 4 |
| Virus Diseases | 4 |
| Hepatitis, Chronic | 3 |
| Bronchiolitis Obliterans Syndrome | 2 |
| Hepatitis, Viral, Human | 2 |
Trials
Showing 1 to 25 of 161. Each trial links to its page on Pharma Observatory.
61 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.